has reported Standalone financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 1.4126 crores during the period ended March 31, 2023 as compared to Rs. 1.4719 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. 0.0077 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 0.0316 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. 0.02 for the period ended March 31, 2023 as compared to Rs. 0.08 for the period ended December 31, 2022.
Total Income | ₹1.4126 crs | ₹1.4719 crs | -4.03% |
Net Profit | ₹0.0077 crs | ₹0.0316 crs | -75.63% |
EPS | ₹0.02 | ₹0.08 | -75.00% |
Financial Results (Q4 FY2023) - YoY Comparison The company has reported total income of Rs.1.4126 crores during the period ended March 31, 2023 as compared to Rs.1.3970 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.0.0077 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.0.0331 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.0.02 for the period ended March 31, 2023 as compared to Rs.0.08 for the period ended March 31, 2022.
Total Income | ₹1.4126 crs | ₹1.3970 crs | 1.12% |
Net Profit | ₹0.0077 crs | ₹0.0331 crs | -76.74% |
EPS | ₹0.02 | ₹0.08 | -75.00% |
Financial Results (Year Ended FY2023) - YoY Comparison The company has reported total income of Rs.2.8845 crores during the Financial Year ended March 31, 2023 as compared to Rs.2.7476 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.0.0393 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.0.0379 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.0.10 for the Financial Year ended March 31, 2023 as compared to Rs.0.09 for the Financial Year ended March 31, 2022.
Total Income | ₹2.8845 crs | ₹2.7476 crs | 4.98% |
Net Profit | ₹0.0393 crs | ₹0.0379 crs | 3.69% |
EPS | ₹0.10 | ₹0.09 | 11.11% |
Source : Equity Bulls
Keywords
GangaPharmaceuticals
Q4FY23
FY2023
ResultUpdate